The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 10, 2022
Filed:
Nov. 21, 2017
Applicant:
Kcl Therapeutics, Inc, La Mesa, CA (US);
Inventors:
Harry M. Lander, La Mesa, CA (US);
David R. Koos, La Mesa, CA (US);
Assignee:
KCL Therapeutics, Inc., La Mesa, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 311/08 (2006.01); C07D 311/12 (2006.01); A61K 31/366 (2006.01); A61K 31/4706 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61K 31/4245 (2006.01); A61K 31/496 (2006.01); A61K 45/06 (2006.01); A61K 31/5377 (2006.01); A61P 37/06 (2006.01); A61K 35/17 (2015.01);
U.S. Cl.
CPC ...
A61K 31/366 (2013.01); A61K 31/4245 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 35/17 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 37/06 (2018.01); C07D 311/08 (2013.01); C07D 311/12 (2013.01);
Abstract
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein to humans.